Search Results

There are 24244 results for: content related to: Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

  1. Natalizumab for induction of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    John K MacDonald and John WD McDonald

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD006097.pub2

  2. Health-related quality of life in multiple sclerosis: effects of natalizumab

    Annals of Neurology

    Volume 62, Issue 4, October 2007, Pages: 335–346, Richard A. Rudick, Deborah Miller, Steve Hass, Michael Hutchinson, Peter A. Calabresi, Christian Confavreux, Steven L. Galetta, Gavin Giovannoni, Eva Havrdova, Ludwig Kappos, Fred D. Lublin, David H. Miller, Paul W. O'Connor, J. Theodore Phillips, Chris H. Polman, Ernst-Wilhelm Radue, William H. Stuart, Andrzej Wajgt, Bianca Weinstock-Guttman, Daniel R. Wynn, Frances Lynn and Michael A. Panzara

    Article first published online : 14 AUG 2007, DOI: 10.1002/ana.21163

  3. Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

    Inflammatory Bowel Diseases

    Volume 13, Issue 1, January 2007, Pages: 2–11, Bruce E. Sands, Richard Kozarek, Jack Spainhour, Charles F. Barish, Scott Becker, Lawrence Goldberg, Seymour Katz, Ronald Goldblum, Rena Harrigan, Deborah Hilton and Stephen B. Hanauer

    Article first published online : 19 DEC 2006, DOI: 10.1002/ibd.20014

  4. You have free access to this content
    Pharmacological Properties, Toxicology and Scientific Rationale for the use of Natalizumab (Tysabri®) in Inflammatory Diseases

    CNS Drug Reviews

    Volume 13, Issue 1, March 2007, Pages: 79–95, Olaf Stüve and Jeffrey L. Bennett

    Article first published online : 24 APR 2007, DOI: 10.1111/j.1527-3458.2007.00003.x

  5. Efficacy of natalizumab in second line therapy of relapsing–remitting multiple sclerosis: results from a multi-center study in German speaking countries

    European Journal of Neurology

    Volume 17, Issue 1, January 2010, Pages: 31–37, N. Putzki, O. Yaldizli, M. Mäurer, S. Cursiefen, S. Kuckert, C. Klawe, M. Maschke, B. Tettenborn and V. Limmroth

    Article first published online : 9 JUL 2009, DOI: 10.1111/j.1468-1331.2009.02728.x

  6. Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1

    Annals of Neurology

    Volume 70, Issue 5, November 2011, Pages: 742–750, Carmen Bozic, Sandra Richman, Tatiana Plavina, Amy Natarajan, James V. Scanlon, Meena Subramanyam, Alfred Sandrock and Gary Bloomgren

    Article first published online : 7 DEC 2011, DOI: 10.1002/ana.22606

  7. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 86, Issue 2, April 2009, Pages: 144–156, Nancy G. Wehner, George Shopp, Ingrid Osterburg, Antje Fuchs, Eberhard Buse and Janet Clarke

    Article first published online : 12 MAR 2009, DOI: 10.1002/bdrb.20193

  8. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

    Annals of Neurology

    Volume 68, Issue 3, September 2010, Pages: 304–310, Richard A. Rudick, Paul W. O'Connor, Chris H. Polman, Andrew D. Goodman, Soma S. Ray, Nancy M. Griffith, Stephanie A. Jurgensen, Leonid Gorelik, Fiona Forrestal, Alfred W. Sandrock and Susan E. Goelz

    Article first published online : 24 AUG 2010, DOI: 10.1002/ana.22107

  9. You have full text access to this OnlineOpen article
    Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 4, April 2015, Pages: 373–387, Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, Maria Trojano, Helmut Butzkueven and on behalf of the MSBase Investigators and the TOP investigators

    Article first published online : 27 FEB 2015, DOI: 10.1002/acn3.180

  10. Crohn's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt019

  11. You have free access to this content
    The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

    British Journal of Haematology

    Volume 155, Issue 4, November 2011, Pages: 438–448, Klaus Podar, Alexander Zimmerhackl, Mariateresa Fulciniti, Giovanni Tonon, Ursula Hainz, Yu-Tzu Tai, Sonia Vallet, Niels Halama, Dirk Jäger, Dian L. Olson, Martin Sattler, Dharminder Chauhan and Kenneth C. Anderson

    Article first published online : 19 SEP 2011, DOI: 10.1111/j.1365-2141.2011.08864.x

  12. Effects of natalizumab, an α4 integrin inhibitor, on the development of Hartley guinea pigs

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 86, Issue 2, April 2009, Pages: 98–107, Nancy G. Wehner, George Shopp, Meredith S. Rocca and Janet Clarke

    Article first published online : 17 MAR 2009, DOI: 10.1002/bdrb.20189

  13. Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study

    Acta Neurologica Scandinavica

    Volume 126, Issue 5, November 2012, Pages: 306–314, R. Lanzillo, M. Quarantelli, S. Bonavita, G. Ventrella, G. Lus, G. Vacca, A. Prinster, G. Orefice, G. Tedeschi and V. Brescia Morra

    Article first published online : 23 NOV 2011, DOI: 10.1111/j.1600-0404.2011.01622.x

  14. Natalizumab effects on immune cell responses in multiple sclerosis

    Annals of Neurology

    Volume 59, Issue 5, May 2006, Pages: 748–754, Masaaki Niino, Caroline Bodner, Marie-Lune Simard, Sudabeh Alatab, Dawn Gano, Ho Jin Kim, Manuela Trigueiro, Denise Racicot, Christine Guérette, Jack P. Antel, Alyson Fournier, Francois Grand'Maison and Amit Bar-Or

    Article first published online : 21 APR 2006, DOI: 10.1002/ana.20859

  15. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis

    Annals of Neurology

    Volume 75, Issue 6, June 2014, Pages: 925–934, Spyridon Chalkias, Xin Dang, Evelyn Bord, Marion C. Stein, R. Philip Kinkel, Jacob A. Sloane, Maureen Donnelly, Carolina Ionete, Maria K. Houtchens, Guy J. Buckle, Stephanie Batson and Igor J. Koralnik

    Article first published online : 10 JUN 2014, DOI: 10.1002/ana.24148

  16. Effects of natalizumab, an α4 integrin inhibitor, on fertility in male and female guinea pigs

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 86, Issue 2, April 2009, Pages: 108–116, Nancy G. Wehner, Michael Skov, George Shopp, Meredith S. Rocca and Janet Clarke

    Article first published online : 12 MAR 2009, DOI: 10.1002/bdrb.20191

  17. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  18. Immune surveillance in multiple sclerosis patients treated with natalizumab

    Annals of Neurology

    Volume 59, Issue 5, May 2006, Pages: 743–747, Olaf Stüve, Christina M. Marra, Keith R. Jerome, Linda Cook, Petra D. Cravens, Sabine Cepok, Elliot M. Frohman, J. Theodore Phillips, Gabriele Arendt, Bernhard Hemmer, Nancy L. Monson and Michael K. Racke

    Article first published online : 21 APR 2006, DOI: 10.1002/ana.20858

  19. Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 86, Issue 2, April 2009, Pages: 117–130, Nancy G. Wehner, George Shopp, Satoru Oneda and Janet Clarke

    Article first published online : 10 MAR 2009, DOI: 10.1002/bdrb.20190

  20. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

    Annals of Neurology

    Volume 69, Issue 1, January 2011, Pages: 83–89, Martin Gunnarsson, Clas Malmeström, Markus Axelsson, Peter Sundström, Charlotte Dahle, Magnus Vrethem, Tomas Olsson, Fredrik Piehl, Niklas Norgren, Lars Rosengren, Anders Svenningsson and Jan Lycke

    Article first published online : 8 DEC 2010, DOI: 10.1002/ana.22247